Although it is unclear whether AKR1B1 expression is a biomarker for cancer or a potential target for cancer treatment, several studies have shown that AKR proteins play central roles in the cellular response to osmotic, electrophilic, and oxidative stress [39,40], suggesting potential applications in cancer therapy. The gene discussed is AKR1B1; the disease is cancer.